DIRS.INFO The most relevant business & tech news

☆ Most doses of Eli Lilly's Zepbound, Mounjaro in short supply through June, FDA says
▼ + stars: | 2024-04-17 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +1 min

An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City, U.S., December 11, 2023. Most doses of Eli Lilly 's highly popular weight loss drug Zepbound and diabetes counterpart Mounjaro will be in short supply through the second quarter of this year as demand jumps, according to an update on the Food and Drug Administration's drug shortage database on Wednesday. All doses of Zepbound and Mounjaro besides the 2.5-milligram versions of both treatments are in a shortage. "We recognize this situation may cause a disruption in peoples' treatment regimens and areworking with purpose and urgency to help meet the surge in demand," an Eli Lilly spokesperson said in a statement to CNBC. The company expects its investments in manufacturing and supply capacity "to progressively increase production of our medicines throughout 2024 and beyond," they added.

Persons: Eli Lilly’s, Eli Lilly Organizations: Food, Novo Nordisk, CNBC Locations: New York City, U.S

☆ Promise of Eli Lilly's weight-loss drug for sleep apnea adds another reason to own the stock
▼ + stars: | 2024-04-17 | by ( Kevin Stankiewicz | ) www.cnbc.com time to read: +7 min

Eli Lilly said it plans to ask U.S. regulators to expand Zepbound's label to include obstructive sleep apnea, or OSA, later this year. Shares of Eli Lilly have ridden the GLP-1 craze to new heights over the past few years. The current standard of care for obstructive sleep apnea is positive airway pressure, or PAP, machines, which help keep patients' airways open while they sleep. Analysts projected obstructive sleep apnea revenue of $3 billion. An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City on Dec. 11, 2023.

Persons: Eli Lilly, Zepbound, it's, Mounjaro, Lilly, Jim Cramer, Jim, Eli Lilly YTD, Morgan Stanley, Jim Cramer's, Eli Lilly’s, Brendan Mcdermid Organizations: Novo Nordisk, GLP, OSA, Mayo, U.S, CNBC, Cleveland Clinic, National Council, Aging, Deutsche Bank, American Diabetes Association, Novo Nordisk's Ozempic, Bank of America Locations: U.S, Novo, New York City

☆ Weight loss drug Zepbound may help people with obstructive sleep apnea, drugmaker says
▼ + stars: | 2024-04-17 | by ( Jen Christensen | ) edition.cnn.com time to read: +4 min

CNN —Zepbound, a popular weight loss drug, also seems to help people with obstructive sleep apnea, drugmaker Eli Lilly said Wednesday. Based on results from trials in people with sleep apnea, the company said it plans to submit the material to the US Food and Drug Administration to potentially expand the use of Zepbound for obstructive sleep apnea. Obstructive sleep apnea is a disorder that causes people to briefly stop breathing while they are sleeping, sometimes several times an hour. While people are more at risk for obstructive sleep apnea as they get older, it often develops when people gain weight and have overweight or obesity. Some doctors have been prescribing the weekly injection off label to people with obstructive sleep apnea, and Lilly has been testing the drug for obstructive sleep apnea since June 2022.

Persons: CNN —, Eli Lilly, Lilly, didn’t, Dr, Sanjay Gupta, CNN’s Meg Tirrell, Amanda Sealy Organizations: CNN, Food and Drug Administration, World Health, US Food and Drug Administration, CNN Health, American Diabetes Association

☆ Stocks making the biggest moves midday: United Airlines, Travelers, Abbott Laboratories and more
▼ + stars: | 2024-04-17 | by ( Samantha Subin | ) www.cnbc.com time to read: +3 min

Quarterly revenue came in at $12.54 billion, topping an LSEG estimate of $12.45 billion. Travelers said it generated $4.69 in earnings per share on $10.18 billion in revenue. Interactive Brokers — Shares popped 3% after Interactive Brokers posted quarterly results that came in slightly ahead of Wall Street's expectations. J.B. Hunt posted earnings of $1.22 per share on $2.94 billion in revenue. Alcoa is set to report earnings after the bell.

Persons: LSEG, Eli Lilly, ASML, Hunt, Kate Spade, Abbott, Joe Biden's, Jefferies, —, Jesse Pound, Hakyung Kim, Pia Singh, Michelle Fox, Alex Harring, Sarah Min Organizations: United Airlines —, Travelers Companies, Travelers, U.S, Interactive, Hunt Transport Services, The New York Times, Federal Trade Commission, Versace, Capri Holdings, Autodesk —, Autodesk, Bancorp — U.S, Bancorp, Abbott Laboratories, FactSet, Alcoa Locations: China

☆ Stocks making the biggest premarket moves: Eli Lilly, Travelers, United Airlines, Alcoa and more
▼ + stars: | 2024-04-17 | by ( Michelle Fox | ) www.cnbc.com time to read: +3 min

Travelers — Shares fell nearly 5% after the insurance company reported an earnings and revenue miss for its first quarter. Revenue was $10.18 billion compared with the $10.51 billion expected. J.B. Hunt Transport Services — Shares sank 8% a day after the transportation and logistics company reported an earnings and revenue miss for its first quarter. ASML Holding — U.S.-listed shares sank 5% after the Dutch semiconductor company posted revenue and new bookings that came in below consensus estimates. Omnicom — The stock added nearly 3% a day after the communications company reported an earnings and revenue beat for its first quarter.

Persons: Eli Lilly, ResMed, Eli Lilly's, Zepbound, J.B, Hunt, Joe Biden, TD Cowen, Ferrari, Bernstein, —, Dealbook, Kate Spade, Jesse Pound, Hakyung Kim, Sarah Min, Fred Imbert Organizations: LSEG, Revenue, Travelers, United Airlines, Hunt Transport, ASML, Urban, Jefferies, Autodesk, Alcoa, United Steelworkers, Ferrari, Abbott, Abbott Laboratories, New York Times, Federal Trade Commission Locations: J.B, China, Pittsburgh

☆ Another perk of weight-loss drugs? Eli Lilly's Zepbound may alleviate sleep apnea, too
▼ + stars: | 2024-04-17 | by ( Hilary Brueck | ) www.businessinsider.com time to read: +4 min

GLP-1 drugs were originally developed to treat type 2 diabetes. Drugmakers are discovering the injections may also aid weight loss, heart issues, and sleep apnea. AdvertisementAnother new indication for injectable GLP-1 drugs: better sleep. On Wednesday, drugmaker Eli Lilly announced positive results from a large, phase-3 clinical trial, testing Zepbound (the drug name for tirzepatide) as a treatment for sleep apnea. Related storyAlready, GLP-1 drugs have been indicated for the treatment of:ObesityHeart diseaseAdvertisementIn clinical trials, GLP-1 drugs have also shown some promise for treating other conditions, including:Non-alcoholic fatty liver diseaseAddictionDepressionParkinson's and Alzheimer'sCancerThese breakthroughs may be tied to the gut-brain connectionScientists think that the main reason GLP-1 drugs work well is because of their effect on our body's gut-brain connection.

Persons: —, drugmaker Eli Lilly, Eli Lilly, KATERYNA, Daniel Drucker, GLP, Eric Topol Organizations: Service, Food and Drug Administration, American Diabetes Association, University of Toronto

☆ If you're worried about a correction and over-invested in Nvidia, replace it with these steady growth stocks instead
▼ + stars: | 2024-04-16 | by ( Sarah Min | ) www.cnbc.com time to read: +2 min

Investors who are concerned they're overexposed to Nvidia could replace the name with these steady growth stocks instead, according to Trivariate Research's Adam Parker. "If NVDA reports that demand is still robust as far as the eye can see, owning AI-exposed semiconductors remains prudent," Parker said. "For those looking to hedge their aggressive AI-semiconductor bets, this group appears prudent," Parker wrote. Berkshire Hathaway surfaced as a large cap growth stock with low correlation to Nvidia , that's also able to beat the market. Charles Schwab was another large cap growth stock with low correlation to Nvidia.

Persons: Trivariate Research's Adam Parker, Parker, Berkshire Hathaway, that's, Eli Lilly, Charles Schwab Organizations: Nvidia, Citi, Waste Management, Emerson Locations: Berkshire

☆ Stocks give up early gains — Here's why a busy week of earnings is good news for investors
▼ + stars: | 2024-04-15 | by ( Jeff Marks | ) www.cnbc.com time to read: +3 min

Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. There is nothing markets hate more than uncertainty, which is why stocks struggled to hold onto their early gains. As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB.

Persons: Jim Cramer, Morgan Stanley, Goldman Sachs, Charles Schwab bode, Eli Lilly, It's, Jim Cramer's, Jim Organizations: CNBC, Dow Jones, Abbott Laboratories, Jim Cramer's Charitable Locations: East

☆ EU probe of weight loss and diabetes drugs like Wegovy, Ozempic finds no link to suicidal thoughts
▼ + stars: | 2024-04-12 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +3 min

European Union drug regulators found no evidence that highly popular weight loss and diabetes drugs such as Wegovy and Ozempic are linked to an increased risk of suicidal thoughts and self-injury, the regulator said Friday. The review examined several drugs from Novo Nordisk , including Wegovy and Ozempic. Clinical trials from Novo Nordisk and Eli Lilly have not demonstrated a link between GLP-1s and suicidal thoughts. The probe also included other active ingredients in older weight loss and diabetes drugs, including dulaglutide, exenatide and lixisenatide. Results from another study conducted by the agency also did not support a link between GLP-1 drugs and the risk of suicidal thoughts.

Persons: Eli Lilly, couldn't, Liraglutide Organizations: Novo Nordisk, European Union, European Medicines Agency, U.S . Food, Drug Administration, EMA, Icelandic Medicines Agency Locations: London, Britain, Novo, U.S, GLP, Wegovy, Ozempic

☆ Eli Lilly's top-selling drug last year is softening. But it may not matter for the stock
▼ + stars: | 2024-04-12 | by ( Kevin Stankiewicz | ) www.cnbc.com time to read: +5 min

Sales of some Eli Lilly drugs — including its best-selling product last year — appear to be softening, according to Wall Street analysts. JPMorgan flagged similar trends for Trulicity, which led all Lilly drugs with $7.13 billion in sales for all of 2023. The thesis is predicated on Eli Lilly growing faster than the broader pharmaceutical industry for years to come. Over the past three years, shares of Eli Lilly have soared nearly 300%, compared with a 24% gain for the S & P 500 . A box of the drug trulicity, made by Eli Lilly Pharmaceutical, sits on a counter at a pharmacy in Provo, Utah, January 9, 2020.

Persons: Eli Lilly, Wells, Lilly, Mounjaro, Jim Cramer, tirzepatide, Zepbound, Eli Lilly's, Novo, Wegovy, drugmaker, Jim Cramer's, Jim, Eli Lilly Pharmaceutical, George Frey Organizations: Wall Street, JPMorgan, Club, Novo Nordisk, Novo, BMO Capital Markets, Drug Administration, FDA, The Club, CNBC Locations: Wells Fargo, Trulicity, Tirzepatide, Danish, Lilly, Provo , Utah

☆ 10 things to watch in the stock market Friday, including bank earnings and portfolio stock price target bumps
▼ + stars: | 2024-04-12 | by ( Jeff Marks | ) www.cnbc.com time to read: +3 min

The bank reports $1.26 in earnings per share vs. $1.11 expected. A round of price target increases on Constellation Brands after its strong quarter and upside guide Thursday. Following the release and conference call, we reiterated our buy-equivalent 1 rating on shares and raised our price target to $300 from $270. A couple more price target cuts on Tesla . BMO starts coverage on the Novo Nordisk shares with a buy-equivalent outperform rating and a $163 per share price target.

Persons: Wells Fargo, Jefferies, Rosenblatt, Wells, Wedbush's Dan Ives, robotaxi, Eli Lilly, Jim Cramer's, Jim Cramer, Jim Organizations: Bank, JPMorgan, Citigroup, Constellation Brands, BMO, Devices, Arista Networks, Citi, EV, Boeing, Novo Nordisk, Jim Cramer's Charitable, CNBC Locations: China, Tesla, Wells Fargo

☆ Robotaxi regulators say Tesla hasn’t contacted them about plans teased by Musk
▼ + stars: | 2024-04-11 | by ( David Ingram | ) www.cnbc.com time to read: +7 min

Musk hinted at his plans in a brief post late Friday afternoon on X, writing: "Tesla Robotaxi unveil on 8/8." Musk has talked about a robotaxi service for years. In 2019, he discussed plans to launch a robotaxi fleet using Tesla vehicles that people had leased and then returned. Musk has also talked about a robotaxi service with decentralized ownership, in which Tesla owners could rent out their cars for fares. Amazon subsidiary Zoox has said it has authorization from Nevada to operate a robotaxi service, which hasn't launched.

Persons: robotaxis, Tesla, Elon Musk, Brad Templeton, Templeton, Cruise, Musk, Zoox, hasn't, Eli Rohl Organizations: The California Department of Motor Vehicles, California Public Utilities Commission, NBC, DMV, Google, General Motors, Phoenix, Toyota, Car Dealers Association, Reuters, Cruise, Transportation Department, Nevada DMV, The, The Nevada DMV, California DMV Locations: California, San Francisco, Los Angeles, leaseholders, Arizona, Nevada, The Nevada

☆ Brady, Jeter, Eli and Peyton Manning headline Fanatics’ effort to build a comic-con of sports
▼ + stars: | 2024-04-11 | by ( Ian Thomas | ) www.cnbc.com time to read: +3 min

Lance Fensterman, CEO of Fanatics Events and the former president of ReedPop — where he produced pop culture events like New York Comic-Con, Complex-Con, and Star Wars Celebration — said he sees several parallels between pop culture fans and sports fans. However, he noted, while events like New York Comic-Con have evolved to embrace multiple difference fanbases and communities, the sports-focused event space is "ready to be disrupted a bit." Tom Brady, Derek Jeter, Eli and Peyton Manning, Kevin Durant, Sabrina Ionescu and Hulk Hogan are just some of the big sports names scheduled to appear, Fensterman said. "Those are the moments that we get excited about, and we just don't see it being done anywhere else in the world of live sports events," Fensterman said. The festival was the highest-grossing and most-attended fan event in WWE history, according to Fanatics.

Persons: Con, Lance Fensterman, ReedPop, —, You've, Fensterman, Tom Brady, Derek Jeter, Eli, Peyton Manning, Kevin Durant, Sabrina Ionescu, Hulk Hogan Organizations: New York, Star, Fest, Javits Center, NFL, NBA, WNBA, MLB, NHL, MLS, UFC, WWE, Endeavor, IMG, WWE's Locations: New York City, U.S, New, Philadelphia

☆ Cramer says stocks that pulled back Tuesday still 'have everything going for them'
▼ + stars: | 2024-04-09 | by ( Julie Coleman | ) www.cnbc.com time to read: +2 min

CNBC's Jim Cramer reviewed Tuesday's market action, saying stocks that saw losses — like Nvidia and Eli Lilly — remain winners but had simply run too much. "The stocks that pulled back today have everything going for them, except that they've already run so much that they've become vulnerable," he said. Cramer used Nvidia , one of his favorite stocks, as an example. He also suggested tax season played a role in deciding Tuesday's winners and losers. "What a terrific time to take some profits of winning stocks to pay for the stocks' gains," Cramer said.

Persons: CNBC's Jim Cramer, Eli Lilly —, they've, Cramer, Tuesday's, Gaudi, Blackwell, Eli Lilly, he'd, you've Organizations: Nvidia, Intel Locations: Germany

Thousands of residents and visitors viewed the event from the baseball field at Hidalgo de Dolores Elementary School. Residents began renting out their homes after area hotels reached capacity. ET Cuatro Ciénegas Amid a vast landscape of gypsum dune fields — formed over millions of years — spectators viewed the eclipse. ET Dallas Crowds set up their picnic blankets alongside the Trinity River, which runs through Dallas, one of the largest cities to experience the total eclipse. ET Russellville More than 100 couples were married in a giant ceremony just minutes before the eclipse, during the Total Eclipse of the Heart festival.

Persons: — Dennis Overbye, Andrés Manuel López Obrador, ” Federico Garza, ”, David Bowie, Pink Floyd, Sun Ra, Taylor Swift Organizations: North America Today, Hidalgo de Dolores Elementary School, Nazas, Residents, Dallas Crowds, Russellville, Eclipse, Liverpool, Illinois Department of Transportation, Indiana, Indianapolis, Indianapolis Zoo, Lucas Oil, Roll Hall of Fame, Attica Railroad, Eclipse Fest, Buffalo State, Syracuse, Syracuse Mets, Worcester Red Sox, Hotels, Montreal Locations: North America, — Dennis Overbye Mexico, Sinaloa State, Mazatlán, Mexico, Hidalgo, Texas, Eagle, Dallas, Arkansas, Ozark, . Illinois, Southern Illinois, Midwest, . Ohio, Lake Erie, Cleveland, Taylor Swift . New York, Niagara Falls, England, Burlington , Vt, Burlington, Lake Champlain, Maine, Canada, U.S, Montreal, Fredericton , New Brunswick, New Brunswick, EclipseFest

☆ Dr. Bob, 75, Knows Aging’s Toll. He Wonders if Biden and Trump Do.
▼ + stars: | 2024-04-08 | by ( Eli Saslow | Erin Schaff | ) www.nytimes.com time to read: 1 min

“What’s hurting you most today?” he asked Nancy Scoblic, 79. “Let me take out my list,” she said. I’ve got a spot on my leg and pain in my shoulder. It was behind the closed door of Dr. Bob’s exam room where hundreds of people filled out their advance directives, took cognitive evaluations and tested out their new walkers and hearing aids. It was Dr. Bob who delivered bad news with a farmer’s directness and then sat with families around a hospice bed for hours when the only thing left to do was to pray.

Persons: “, Nancy Scoblic, ”, I’ve, it’ll, Bob —, Ortonville, Bob

☆ Modelo maker Constellation Brands is primed for market share gains but we still see one issue with the company
▼ + stars: | 2024-04-07 | by ( Paulina Likos | ) www.cnbc.com time to read: +7 min

Constellation Brands stock is looking like it could be ready to break out, with its strong beer business well-positioned for market share gains in the upcoming fiscal year. Morgan Stanley anticipates Constellation to continue gaining market share at the expense of Bud Light during this period. Since Constellation tends to boast industry-leading results in its beer business, we're confident it will deliver strong numbers again next week. Over the past few years, Constellation has been trying to boost sales in its wine and spirits business — shifting from lower-priced brands to more premium names. While wine and spirits make up a small part of Constellation's overall business, Jim has said it must go.

Persons: It's, Jim Cramer, Morgan Stanley, Jeff Marks, Jim, Bud Light, Marks, Piper Sandler, Newlands, Kim Crawford, Eli Lilly, Elliott, Jim Cramer's, Justin Sullivan Organizations: Constellation Brands, Anheuser, Busch Inbev, Modelo, Nielsen, Cinco de Mayo, Bud Light, Constellation, Piper, Elliott Investment Management, CNBC Locations: Corona, Pacifico, U.S, GLP, Modelo, San Rafael , California

☆ While many flock to see the eclipse, these cultures are doing something different
▼ + stars: | 2024-04-05 | by ( Harmeet Kaur | ) edition.cnn.com time to read: +8 min

CNN —For many people, the upcoming total solar eclipse is a joyous and celebratory occasion. But in other cultures and faith traditions, an eclipse is less spectacle and more spiritual. Having drunk the nectar, Rahu becomes immortal while Ketu dies. Some Christians believe it signals the second coming of ChristPeople visit the Bald Knob Cross near Alto Pass, Illinois, on August 19, 2017 ahead of a total solar eclipse. The New Testament of the Bible contains several mentions of the sky darkening while Jesus was hung on the cross, which some believers associate with a solar eclipse.

Persons: Sanjay Kanojia, Sangeetha Kowsik, Kowsik, Vishnu, Mohini, Ketu, Rahu, Hanuman, ” Kowsik, Ganesha, Lord Hanuman, Fachrul Reza, NurPhoto, Akif Aydin, Muhammad’s, Ibrahim, Aydin, —, Prophet Muhammad, ”, Scott Olson, Jesus Christ, Jesus, Matthew, “, “ Eli, Eli, lema, Joel, Andrea L, Robinson, Brian van der, Evelyn Bahe, ” Bahe, Bahe, Institute’s Nancy C, Maryboy, David Begay, Kristin Fisher Organizations: CNN, Getty, New York University, Atlantic Institute SC, Christ People, Christianity, “, Los Angeles Times, Department of Diné, Sun, Institute’s Locations: Mexico, Canada, Prayagraj, Yamuna, AFP, South India, Lhokseumawe, Indonesia, South Carolina, Alto Pass , Illinois, American, America, it’s, Navajo, Rock , Arizona

☆ Here are Friday's biggest analyst calls: Apple, Tesla, Netflix, Marvell, Ollie's, Snowflake, Eli Lilly, Krispy Kreme & more
▼ + stars: | 2024-04-05 | by ( Michael Bloom | ) www.cnbc.com time to read: +8 min

"We are raising our YE'24 NFLX target price $65 to a street-high $765 driven primarily by a combo of higher '24 and beyond subscriber/ARPU forecasts." "We are upgrading Ollie's Bargain Outlet to a Buy from a Hold rating while raising our price target to $90 from $80, implying 26% upside from current levels." We cut our price target from $2 to $1, still giving ATUS the highest multiple in Cable as optionality. "We are raising our already Street High $330 YE'24 target price $60 to $390 driven primarily by higher premium and to a lesser extent ad supported ARPU forecasts." Jefferies adds Pepsi to the franchise picks list Jefferies said it sees opportunity internationally for Pepsi and raised its price target to $209 per share from $199.

Persons: Marvell, it's, Bernstein, Mizuho, Wells, Piper Sandler, Krispy, JPMorgan, Eli Lilly, LLY, Stifel, Rosenblatt, Snowflake, Jefferies, underperform KBW, Daiwa, Tesla, KBW, Monness Crespi Hardt Organizations: Netflix, Bank of America, Apple, Amazon Web Services, RBC, Eaton, Piper, JPMorgan, Technologies, Cable, Spotify, BMO, Royal Bank, Pepsi, Fox, Fox News, Digital, Citi, Express, American Express Locations: NY, McDonald's, USA, Toronto, Snowflake, U.S

☆ Elon Musk’s X is back to giving out free blue checks. It’s no surprise they were a tough sell
▼ + stars: | 2024-04-04 | by ( Clare Duffy | ) edition.cnn.com time to read: +5 min

New York CNN —It appears that Elon Musk has finally (mostly) given up on trying to make paid blue checks on X a thing. The return of the free blue check may be a sign that the blue check subscription business hasn’t panned out the way that Musk hoped. Musk’s purge of legacy blue checks was a messy, months-long process. And when anyone could buy a blue check, it was no longer an exclusive symbol that conferred some kind of status. Within hours of the unpaid blue checks reappearing, users were sharing advice about how to ensure they didn’t show up on their profiles.

Persons: Elon Musk, Musk, —, hasn’t, ”, Jason Goldman, Twitter’s, Eli Lilly, Eli Lilly’s, Stephen King, LeBron James, Matt Navarra, ” Goldman, X, “ Dear Elon Organizations: New, New York CNN, Twitter, Nintendo, Elon Locations: New York

☆ Diabetes drug similar to Ozempic helped slow progression of Parkinson's disease in small trial
▼ + stars: | 2024-04-04 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +3 min

A highly popular class of drugs for diabetes and obesity is showing early potential to help patients with Parkinson's disease, too. But more research is needed to determine whether newer iterations of GLP-1s from Novo Nordisk and Eli Lilly may also help Parkinson's patients. The trial followed 156 people with early Parkinson's disease for a year. But one group was given an additional daily injection of Sanofi's drug, while the other was given a placebo. But use of Sanofi's drug was associated with an increased risk of gastrointestinal side effects, which are common across all GLP-1s.

Persons: Eli Lilly, Sanofi, drugmaker Organizations: Sanofi, Novo Nordisk, The New England, French Ministry of Health, Prevention, CNBC Locations: Novo, France, The

☆ The CEO of a weight-loss ETF that's crushing the S&P 500 since launching in November shares 4 stocks he sees with over 100% upside in the next 12 months
▼ + stars: | 2024-04-04 | by ( William Edwards | ) www.businessinsider.com time to read: +5 min

Weight-loss drugs like Ozempic, Wegovy, and Mounjaro are all the rage, and investors are noticing. Since launching in November, the Tema Obesity and Cardiometabolic ETF (HRTS) is up 24%, crushing the S&P 500's 14.8% returns over the same period. Pot and his colleagues at Tema are bullish on the weight-loss drug stocks due to the wave of demand they see coming. Novo Nordisk estimates that only 2% of obesity cases are being treated by weight-loss drugs, Pot said. 4 weight-loss drug stocks to watchPot listed two larger stocks and two smaller ones in the space.

Persons: Maurits Pot, Janus Henderson, Pot, Goldman Sachs, Geoff Meacham, Charles Barkley, Elon Musk, Whoopi Goldberg, Eli Lilly, Lilly Organizations: VanEck Pharmaceutical, Business, World Health Organization, Novo Nordisk, Bank of America, Bank, Nordisk, FDA, Amazon, Therapeutics, Zealand Pharma Locations: Tema, GLP, Danish, it's

Hedge fund managers gathered Wednesday at the 2024 Sohn Investment Conference in New York to share their best investment ideas. It kicked off with "Next Wave Sohn," a session that features ideas from rising stars within the hedge fund industry. Endocrinology is an $8 billion market, but the cumulative market size, including the company's future therapy targets, is upward of $200 billion, which includes estimates for future obesity drugs, the investor said. It has CA$75 billion market cap with an "unbelievable record of success," according to the investor. The short seller noted that the company has a $5 billion market cap with about $4.8 billion of debt.

Persons: Sohn, Eric Wolff, Wolff, Michelle Ross, Cushing, Ross, Eli Lilly, Crinetics, XBI, Nikhil Daftary, Alimentation, Daftary, Chris Drose, Nate Koppikar, Fahmi Quadir Organizations: Investment, Gumshoe Capital Management Investment, Pason Systems Energy, Pason Systems, Gumshoe Capital Management, StemPoint, Pharmaceuticals, Crinetics Pharmaceuticals, StemPoint Capital, Endocrinology, Novo Nordisk, P Biotech, NK Capital Investment, NK Capital, Starbucks, McDonalds, Bleecker Street Capital, Orso Partners, Justice Department, Federal Trade Commission, Safkhet, Global Education Locations: New York, Canada, U.S

☆ ‘The Matrix’ has a fifth film in the works and, no, this is not a simulation
▼ + stars: | 2024-04-03 | by ( Alli Rosenbloom | ) edition.cnn.com time to read: +2 min

The beloved “Matrix” movie franchise is expanding with an upcoming fifth installment, with the film’s original co-writer and co-director Lana Wachowski leading the charge as executive producer. According to a press release from the film’s studio Warner Bros. Motion Picture Group sent on Wednesday, Oscar-nominated screenwriter Drew Goddard will write and direct the film alongside his producing partner Sarah Esberg. (Warner Bros. Motion Picture Group is a subsidiary of CNN’s parent company, Warner Bros. “The Matrix” premiered in 1999 and stars Reeves, Laurence Fishburne, Hugo Weaving and Carrie-Anne Moss. It went on to win four Academy Awards and spawned three sequels, including “The Matrix Reloaded” and “The Matrix Revolutions” in 2003, and “The Matrix Resurrections” in 2021.

Persons: Lana Wachowski, Oscar, Drew Goddard, Sarah Esberg, Jesse Ehrman, Warner, Goddard “, Lana, Lilly, Wachowski, Keanu Reeves, Reeves, Goddard, ’, Laurence Fishburne, Hugo Weaving, Carrie, Anne Moss Organizations: CNN, Warner Bros, Warner Bros ., Motion Locations: ”

☆ Here are Tuesday's biggest analyst calls: Nvidia, Meta, Boeing, Eli Lilly, Disney, Coca-Cola, Grindr & more
▼ + stars: | 2024-04-02 | by ( Michael Bloom | ) www.cnbc.com time to read: +8 min

Here are Tuesday's biggest calls on Wall Street: Oppenheimer reiterates Nvidia as outperform Oppenheimer said it's sticking with its outperform rating on shares of Nvidia. Citi reiterates Eli Lilly as buy Citi said the biopharma company is "riding the GLP-1 rocket." Citi downgrades Clorox to neutral from buy Citi said that the bullish thesis for the stock has largely played out for now. Citi upgrades Estee Lauder to buy from neutral Citi said it sees a "topline inflection point" for the stock. Barclays upgrades Array Technologies to overweight from equal weight Barclays said it sees share gains for the solar company.

Persons: Oppenheimer, McCormick, Argus, Needham, it's, Nelson Peltz, Melius, Horton, Citi, Eli Lilly, Estee Lauder, ARRY, JMP, Piper Sandler, Piper, Nio, CFRA, Goldman Sachs, Goldman, Blackstone, Petco Organizations: Nvidia, JPMorgan, Disney, Boeing, Citi, Coca, MTH, RBC, GE Vernova, General Electric, Bank of America, Meta, Travel, Barclays, Eaton, MI, Olema Pharmaceuticals, UBS, Bank of, of America Locations: underperform, LEN, DHI, Asia, Eaton, 4Q23

Search resuls for: "Eli Lilly

25 mentions found